1. Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia;
2. Department of Hematology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands;
3. Memorial Sloan Kettering Cancer Centre, New York, NY;
4. China Novartis Institutes for Biomedical Health, Shanghai, China; and
5. The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia